The Memo: Hy2Care Restoring Cartilage and Redefining Recovery

Hy2Care was founded in 2014 by Dr. Sanne Both and Prof. Marcel Karperien at the University of Twente. Both brought firsthand experience of the shortcomings in existing cartilage treatments. Karperien, a leading voice in cartilage biology, partnered with her to translate frustration into innovation. This blog is originally published here: https://shorturl.at/OMpWM

The Memo: NICE Surgical Solutions Shifting the Paradigm in Colorectal Surgery

The idea for NICE Surgical was born in the operating room. Dr. Eric Haas, Chief of Colon & Rectal Surgery at Houston Methodist, had pioneered a revolutionary approach called the NICE procedure, combining Natural Orifice Specimen Extraction (NOSE) with Intracorporeal Anastomosis (ICA). The technique minimized trauma, improved outcomes, and eliminated the need for large abdominal incisions. To read more about visit here: https://shorturl.at/WhXK9

The Memo: Oath Surgical Rebuilding the System from the Ground Up

After years of investing in and advising surgical innovation from the vantage point of Intuitive Ventures, Oliver Keown is stepping into the founder’s chair—with a bold new vision for the future of outpatient surgery. “At Intuitive, I had the privilege of sitting atop a giant, seeing where surgery was headed,” Keown said. “But I also saw the system’s fragmentation—and a gap no one else was addressing.” This blog is originally published here: https://shorturl.at/kXBg6

LSI Alumni Funding Report April 2025

April was another impressive month of funding for the LSI Alumni, raising over $508 million in new capital across 20 new deals. Our monthly Alumni Funding Update features transactions made by these medical device startups and their investors, as well as links to our proprietary media and coverage of the companies themselves. This blog is originally published here: https://shorturl.at/BXCSP

Medtech in 2025: Key Insights from Q1 Earnings

As we venture into Q2 of 2025, the medtech industry continues to navigate challenges while remaining on a positive growth trajectory. The early earnings reports from major medtech companies provide valuable insights into how the sector is performing and where it is heading. Despite the pressures of ongoing macroeconomic uncertainty, the first quarter of 2025 shows a sector that’s resilient, with many companies reporting strong growth across their key divisions. For more information visit here: https://tinyurl.com/4zycxxms